Mirixa adds asthma program
May 24, 2010
THE Pharmacy Guild’s Mirixa
software platform has launched a
new program which “offers yet
another revenue stream for
pharmacies wanting to deliver
professional services”.
The addition centres on referring
patients as potential participants in
a clinical research program, which
involves helping asthma patients
gain access to a new once daily
medicine.
When dealing with a customer
who fits the required profile, Mirixa
prompts the pharmacist to ask a
small number of questions, and
then subsequently to fax a form for
all valid patients.
For each referral the pharmacy is
paid a $20 professional service fee,
and the patients are later contacted
for further assessment by the
research organisation.
Mirixa Australia general manager,
Roma Cecere, said the new
program was a great opportunity
for both pharmacies and patients.
“The clinical research industry is
worth $450 million to the
Australian economy,” she said.
“Researchers require quality
patients for these studies and we all
know that pharmacies see a lot of
patients.
“Research referral is a perfect fit
for pharmacy,” Cecere added.
Mirixa is inviting pharmacies
interested in signing up for the
program to find out more on
contact@mirixa.com.au.
The above article was sent to subscribers in Pharmacy Daily's issue from 24 May 10To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 24 May 10
